KATHERINE ADLER: Open Payments
NPI 1700546934 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 23 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $514 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $69 |
| Astellas Pharma US Inc | 3 | $62 |
| PFIZER INC. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Novo Nordisk Inc | 3 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Becton, Dickinson and Company | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
Products named: Sunosi, Veozah, SHINGRIX, LEQVIO, NURTEC ODT, BD Onclarity, Ozempic, VOQUEZNA.
Industry payments across WA — which companies pay providers there.
